| Report Title | Price | Action |
|---|---|---|
| Cells Expressing Somatostatin Receptor Type 2 (SRIF1 or SSTR2) - Drugs in Development, 2021
Cells Expressing Somatostatin Receptor Type 2 (SRIF1 or SSTR2) - Drugs in Development, 2021 Summary Cells Expressing Somatostatin Receptor Type 2 (S...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Ornithine Decarboxylase (ODC or ODC1 or EC 4.1.1.17) - Drugs in Development, 2021
Ornithine Decarboxylase (ODC or ODC1 or EC 4.1.1.17) - Drugs in Development, 2021 Summary Ornithine Decarboxylase (ODC or ODC1 or EC 4.1.1.17) - Dru...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or N Sam or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) - Drugs in Development, 2021
Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or N Sam or Proto Oncogene c Fgr or CD331...
Published: Apr-2021 | No. of Pages: 105
|
$ 3000 | |
| General Anesthetic Effect (Central Nervous System) - Drugs in Development, 2021
General Anesthetic Effect (Central Nervous System) - Drugs in Development, 2021 Summary General Anesthetic Effect (Central Nervous System) - Drugs i...
Published: Apr-2021 | No. of Pages: 40
|
$ 2000 | |
| Ductal Carcinoma In Situ (Oncology) - Drugs in Development, 2021
Ductal Carcinoma In Situ (Oncology) - Drugs in Development, 2021 Summary Ductal Carcinoma In Situ (Oncology) - Drugs in Development, 2021 provides a...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Salivary Gland Cancer (Oncology) - Drugs in Development, 2021
Salivary Gland Cancer (Oncology) - Drugs in Development, 2021 Summary Salivary Gland Cancer (Oncology) - Drugs in Development, 2021 provides an over...
Published: Apr-2021 | No. of Pages: 70
|
$ 2000 | |
| Idiopathic (Essential) Hypertension (Cardiovascular) - Drugs in Development, 2021
Idiopathic (Essential) Hypertension (Cardiovascular) - Drugs in Development, 2021 Summary Idiopathic (Essential) Hypertension (Cardiovascular) - Dru...
Published: Apr-2021 | No. of Pages: 50
|
$ 2000 | |
| Cells Expressing T Cell Surface Glycoprotein CD5 (Lymphocyte Antigen T1/Leu 1 or CD5) - Drugs in Development, 2021
Cells Expressing T Cell Surface Glycoprotein CD5 (Lymphocyte Antigen T1/Leu 1 or CD5) - Drugs in Development, 2021 Summary Cells Expressing T Cell S...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Penicillin Binding Protein 2 (PBP2) - Drugs in Development, 2021
Penicillin Binding Protein 2 (PBP2) - Drugs in Development, 2021 Summary Penicillin Binding Protein 2 (PBP2) - Drugs in Development, 2021 provides i...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Neuropilin 1 (Vascular Endothelial Cell Growth Factor 165 Receptor or CD304 or NRP1) - Drugs in Development, 2021
Neuropilin 1 (Vascular Endothelial Cell Growth Factor 165 Receptor or CD304 or NRP1) - Drugs in Development, 2021 Summary Neuropilin 1 (Vascular End...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Drugs in Development, 2021
Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Drugs in Development, 20...
Published: Apr-2021 | No. of Pages: 85
|
$ 3000 | |
| Hypoxic-Ischemic Encephalopathy (Central Nervous System) - Drugs in Development, 2021
Hypoxic-Ischemic Encephalopathy (Central Nervous System) - Drugs in Development, 2021 Summary Hypoxic-Ischemic Encephalopathy (Central Nervous Syste...
Published: Apr-2021 | No. of Pages: 40
|
$ 2000 | |
| Sarcoidosis (Immunology) - Drugs in Development, 2021
Sarcoidosis (Immunology) - Drugs in Development, 2021 Summary Sarcoidosis (Immunology) - Drugs in Development, 2021 provides an overview of the Sarc...
Published: Apr-2021 | No. of Pages: 45
|
$ 2000 | |
| Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) (Musculoskeletal) - Drugs in Development, 2021
Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) (Musculoskeletal) - Drugs in Development, 2021 Summary Systemic-Onset Juvenile Idiopath...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Cells expressing Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - Drugs in Development, 2021
Cells expressing Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - ...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Periostin (Osteoblast Specific Factor 2 or POSTN) - Drugs in Development, 2021
Periostin (Osteoblast Specific Factor 2 or POSTN) - Drugs in Development, 2021 Summary Periostin (Osteoblast Specific Factor 2 or POSTN) - Drugs in ...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Neurotensin Receptor Type 1 (NTR1 or High Affinity Levocabastine Insensitive Neurotensin Receptor or NTRH or NTSR1) - Drugs in Development, 2021
Neurotensin Receptor Type 1 (NTR1 or High Affinity Levocabastine Insensitive Neurotensin Receptor or NTRH or NTSR1) - Drugs in Development, 2021 Summ...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Drugs in Development, 2021
Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Drugs in Development, 2021...
Published: Apr-2021 | No. of Pages: 80
|
$ 3000 | |
| Movement Disorders (Central Nervous System) - Drugs in Development, 2021
Movement Disorders (Central Nervous System) - Drugs in Development, 2021 Summary Movement Disorders (Central Nervous System) - Drugs in Development,...
Published: Apr-2021 | No. of Pages: 40
|
$ 2000 | |
| Scar (Dermatology) - Drugs in Development, 2021
Scar (Dermatology) - Drugs in Development, 2021 Summary Scar (Dermatology) - Drugs in Development, 2021 provides an overview of the Scar pipeline la...
Published: Apr-2021 | No. of Pages: 55
|
$ 2000 |